Ardent Health, Inc. filed its quarterly report on Form 10-Q with the SEC on August 10, 2026, covering the three and six months ended June 30, 2026, and reporting lower second-quarter net income compared to the same period a year earlier.

Key Highlights

  • Q2 2026 total revenue: $1,622,245 thousand, compared with $1,645,280 thousand in Q2 2025, according to the filing.
  • Q2 2026 net income attributable to Ardent Health, Inc.: $16,899 thousand, down from $72,950 thousand in Q2 2025.
  • Six-month net income attributable to Ardent Health, Inc.: $56,749 thousand for the first half of 2026, versus $114,333 thousand for the first half of 2025.
  • Q2 2026 diluted earnings per share: $0.12, compared with $0.52 in Q2 2025.
  • Cash and cash equivalents: $724,476 thousand as of June 30, 2026, up from $709,601 thousand at December 31, 2025.
  • Total assets: $5,280,078 thousand as of June 30, 2026, versus $5,290,208 thousand at December 31, 2025.
  • Shares outstanding: 141,045,907 shares of common stock as of August 7, 2026, per the filing's cover page.

Ardent Health Q2 2026: Revenue, Expenses, and Balance Sheet Details

According to the Form 10-Q filed by Ardent Health, Inc. (NYSE: ARDT), total revenue for the three months ended June 30, 2026, was $1,622,245 thousand, a decrease from $1,645,280 thousand in the comparable prior-year quarter. For the six months ended June 30, 2026, total revenue was $3,224,115 thousand, compared with $3,142,514 thousand for the six months ended June 30, 2025. The company's total operating expenses for Q2 2026 were $1,579,042 thousand, rising from $1,523,288 thousand in Q2 2025, which the filing shows was driven in part by higher professional fees of $327,843 thousand versus $297,012 thousand in the prior-year period.

The filing reported income before income taxes of $43,203 thousand for Q2 2026, compared with $121,992 thousand for Q2 2025. After income tax expense of $8,514 thousand, net income for the quarter was $34,689 thousand. Of that amount, $17,790 thousand was attributable to noncontrolling interests, leaving $16,899 thousand attributable to Ardent Health, Inc. Basic and diluted earnings per share were both $0.12 for Q2 2026. For the six-month period, basic EPS was $0.40 and diluted EPS was $0.40, against $0.82 basic and $0.81 diluted in the comparable 2025 period.

On the balance sheet as of June 30, 2026, the filing reported total liabilities of $3,538,674 thousand and total equity of $1,746,062 thousand. Long-term debt, less current installments, stood at $1,073,210 thousand. The filing also noted that the condensed consolidated balance sheet included total liabilities of consolidated variable interest entities of $331.2 million as of June 30, 2026. Net cash provided by operating activities for the six months ended June 30, 2026, was $136,513 thousand, compared with $92,703 thousand for the same period in 2025.

What Was Disclosed

Ardent Health, Inc. disclosed unaudited financial results for the three and six months ended June 30, 2026, showing lower quarterly revenue and net income compared to the prior year, alongside balance sheet and cash flow data as of and for the period ended June 30, 2026.